Skip to main content

Table 3 RT-3DE parameters in HCM patients versus control group

From: Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging

  HCM patients (N = 50) Control group (N = 40) p value
LVEDV(ml) 70.12 ± 13.91 85.59 ± 14.94 < 0.001
LVESV (ml) 31.09 ± 6.02 29.46 ± 5.47 0.187
LVSV (ml) 39.94 ± 10.67 56.25 ± 11.68 < 0.001
LVEF(%) 57.17 ± 4.15 65.13 ± 2.95 < 0.001
  1. LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVSV left ventricular stroke volume, LVEF left ventricular ejection fraction. Values are expressed as the mean ± SD